After the sharp rise in the share price in the secondary market, Kunming Longjin Pharmaceutical Co.Ltd(002750) (002750) disclosed on January 6 that the controlling shareholders and actual controllers planned to reduce their total holdings of no more than 3.19% of the company’s shares.
Kunming Longjin Pharmaceutical Co.Ltd(002750) said that Qunxing investment, the controlling shareholder of the company, plans to reduce its holdings of no more than 12.015 million shares from January 28 to July 27, accounting for 3% of the total share capital of the company; Fan xianrussia, the actual controller of the company, plans to reduce his holdings of no more than 775400 shares obtained through centralized bidding transactions, accounting for 0.19% of the total share capital of the company.
The trading market shows that since December 20, Kunming Longjin Pharmaceutical Co.Ltd(002750) share price has started a wave of sharp rise. According to statistics, in the 13 trading days from December 20 to January 6, the company’s share price has increased by 167.49%, and the share price has soared nearly twice. As of the closing on January 6, Kunming Longjin Pharmaceutical Co.Ltd(002750) shares were reported at 19.58 yuan / share, with a total market value of 7.842 billion yuan.
(Beijing business daily)
